EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+4.23%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$153M
AUM Growth
+$153M
(+1.4%)
Cap. Flow
+$572K
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
48.62%
Holding
52
New
6
Increased
15
Reduced
19
Closed
6
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$3.29M |
| 2 |
Travere Therapeutics
TVTX
|
$2.8M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$2.61M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.58M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$2.44M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$2.89M |
| 2 |
CORI
Corium International, Inc.
CORI
|
$2.2M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$2.2M |
| 4 |
KALA BIO
KALA
|
$2.12M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$2.1M |
Sector Composition
| 1 | Healthcare | 49.75% |
| 2 | Financials | 31.55% |
| 3 | Consumer Discretionary | 7% |
| 4 | Industrials | 2.82% |
| 5 | Communication Services | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOVA
26
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $2.44M | 1.59% | +116,146 | New | +$2.44M |
|
27
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.42M | 1.59% | 27,684 +1,428 | +5% | +$125K |
|
|
LJPC
28
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.37M | 1.55% | 117,476 +34,313 | +41% | +$691K |
|
29
KKR & Co
KKR
$124B
| $2.3M | 1.51% | 84,486 -15,073 | -15% | -$411K |
|
30
Heron Therapeutics
HRTX
$207M
| $2.21M | 1.45% | 69,840 -14,635 | -17% | -$463K |
|
|
TFCF
31
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $2.21M | 1.45% | 48,194 -9,816 | -17% | -$450K |
|
32
Citigroup
C
$178B
| $2.2M | 1.44% | 30,606 +795 | +3% | +$57K |
|
33
Trinity Industries
TRN
$2.3B
| $2.16M | 1.41% | 58,898 -2,464 | -4% | -$90.3K |
|
34
Armstrong World Industries
AWI
$8.47B
| $2.16M | 1.41% | 30,992 -6,077 | -16% | -$423K |
|
35
Bread Financial
BFH
$3.09B
| $2.12M | 1.39% | 8,983 -1,417 | -14% | -$335K |
|
36
Iovance Biotherapeutics
IOVA
$807M
| $2.09M | 1.37% | 185,915 +10,318 | +6% | +$116K |
|
37
Morgan Stanley
MS
$240B
| $2.08M | 1.36% | 44,731 +5,199 | +13% | +$242K |
|
38
SLM Corp
SLM
$6.52B
| $2.06M | 1.35% | 184,813 -2,941 | -2% | -$32.8K |
|
|
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.05M | 1.34% | 53,951 -366 | -0.7% | -$13.9K |
|
40
CBRE Group
CBRE
$48.2B
| $2.01M | 1.32% | 45,617 -551 | -1% | -$24.3K |
|
41
Seagate
STX
$35.6B
| $1.87M | 1.23% | 39,579 +2,074 | +6% | +$98.2K |
|
42
TG Therapeutics
TGTX
$4.65B
| $1.3M | 0.85% | 231,989 +36,526 | +19% | +$205K |
|
|
SMC
43
Summit Midstream Corporation
SMC
$282M
| $1.25M | 0.82% | 87,560 | – | – |
|
44
Cocrystal Pharma
COCP
$15.4M
| $382K | 0.25% | 152,916 | – | – |
|
45
Amazon
AMZN
$2.44T
| $316K | 0.21% | 158 | – | – |
|
46
SPDR S&P 500 ETF Trust
SPY
$658B
| $254K | 0.17% | 872 | – | – |
|
|
CORI
47
DELISTED
Corium International, Inc.
CORI
| – | – | -274,651 | Closed | -$2.2M |
|
|
BPMC
48
DELISTED
Blueprint Medicines
BPMC
| – | – | -33,101 | Closed | -$2.1M |
|
|
49
KALA BIO
KALA
$78.8M
| – | – | -154,391 | Closed | -$2.12M |
|
50
Neurogene
NGNE
$264M
| – | – | -209,207 | Closed | -$554K |
|